株式市場ニュース
最新の金融ニュース · 更新 5月 23, 2026
Appleは50周年：ガレージのスタートアップから3兆7300億ドルの巨大企業へ—IPO時の1,000ドルの投資は今日いくらになるか
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
ChatGPTに12歳向けにイーサリアムの説明を求めてみた
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
キア・スターマー氏、マーマレードは誰のもの？ イギリスでマーマレードのブランド名変更は本当に必要になるのか？
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
「グレッグスとは少し違う」：TikTokクリエイターがロンドンの「ジェントリフィケーションされた」ベーカリーをテストする
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
ゴールドマン・サックスはPVH Corp. (PVH) の目標株価を83ドルから93ドルに引き上げる
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND)がフェーズ2 New InsiGHTS試験の週52週データで良好な結果を発表
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research、BeOne Medicines AG (ONC) のカバレッジを開始、アウトパフォーム評価
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
みずほは、Autolus Therapeutics plc (AUTL) の目標株価を 12ドルから10ドルに引き下げました。
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) が Gilead との Ouro Medicines 資産に関する合意を発表
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC CapitalはBicycle Therapeutics plc (BCYC) の目標株価を11ドルから7ドルに引き下げ
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
今すぐ買うべき原油価格100ドルに最適なETF
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen、Marex Group plc (MRX) の目標株価を61ドルから66ドルに引き上げ
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …